Blood pressure in children and adolescents: Current insights

Journal of Hypertension

Volumn 34, Issue 2, 2016, Pages 176-183

  Lurbe, Empar ^a,b   Ingelfinger, Julie R ^c,d  

^a UNIVERSITY OF VALENCIA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Blood pressure; Children; Genetics and epigenetics; Out of office blood pressure; Perinatal programming; Vascular phenotype

Indexed keywords

BIOLOGICAL MARKER;

ADOLESCENT; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CARDIOMETABOLIC RISK; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; CLUSTER ANALYSIS; DISEASE COURSE; EPIGENETICS; HUMAN; MASKED HYPERTENSION; MEDICAL INFORMATION; PHENOTYPE; PREHYPERTENSION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTOLIC HYPERTENSION; WHITE COAT HYPERTENSION; DYSLIPIDEMIAS; GENETIC EPIGENESIS; GENETICS; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; PEDIATRIC OBESITY; PHYSIOLOGY; SYSTOLE;

ADOLESCENT; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CHILD; DYSLIPIDEMIAS; EPIGENESIS, GENETIC; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MASKED HYPERTENSION; METABOLIC SYNDROME X; PEDIATRIC OBESITY; PHENOTYPE; PREHYPERTENSION; RISK FACTORS; SYSTOLE; WHITE COAT HYPERTENSION;

EID: 84957428469     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000790     Document Type: Review

References (76)

1. Blumenthal S, Epps RP, Heavenrich R, Lauer RM, Lieberman E, Mirkin B, et al. Report of the task force on blood pressure control in children. Pediatrics 1977; 59 (5 2 Suppl):I-II; 797-820.
2. National Heart, Lung, and Blood Institute. Report of the Second Task Force on Blood Pressure Control in Children 1987. Pediatrics 1987; 79:1-25.
3. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114:555-576
4. Lurbe E, Cifkova R, Cruickshank JK, Dillon MJ, Ferreira I, Invitti C, et al. European Society of Hypertension. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 2009; 27:1719-1742.
5. Lurbe E. Reference blood pressure values in childhood: an issue to be solved. J Hypertens 2012; 30:1911-1912.
6. Flynn JT. Assessment of blood pressure in children: it's all in the details. J Clin Hypertens 2013; 15:772-773.
7. Falkner B. Recent clinical and translational advances in pediatric hypertension. Hypertension 2015; 65:926-931.
8. Ingelfinger JR. The child or adolescent with elevated blood pressure. N Engl J Med 2014; 370:2316-2325.
9. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
10. Rosner B, Cook NR, Daniels S, Falkner B. Childhood blood pressure trends and risk factors for high blood pressure: The NHANES experience 1988-2008. Hypertension 2013; 62:247-254.
11. Hansen ML, Gunn PW, Kaelber DC. Underdiagnosis of hypertension in children and adolescents. JAMA 2007; 298:874-879.
12. Haas GM, Bertsch T, Schwandt P. Prehypertension and cardiovascular risk factors in children and adolescents participating in the communitybased prevention education program family heart study. Int J Prev Med 2014; 5 (Suppl 1):S50-S56.
13. Lo JC, Sinaiko A, Chandra M, Daley MF, Greenspan LC, Parker ED, et al. Prehypertension and hypertension in community-based pediatric practice. Pediatrics 2013; 131:e415-e424.
14. Acosta AA, Samuels JA, Portman RJ, Redwine KM. Prevalence of persistent prehypertension in adolescents. J Pediatr 2012; 160:757-761.
15. Redwine KM, Acosta AA, Poffenbarger T, Portman RJ, Samuels J. Development of hypertension in adolescents with prehypertension. J Pediatr 2012; 160:98-103.
16. Drukteinis JS, Roman MJ, Fabsitz RR, Lee ET, Best LG, Russell M, Devereux RB. Cardiac and systemic hemodynamic characteristics of hypertension and prehypertension in adolescents and young adults: The Strong Heart Study. Circulation 2007; 115:221-227.
17. Urbina EM, Khoury PR, McCoy C, Daniels SR, Kimball TR, Dolan LM. Cardiac and vascular consequences of prehypertension in youth. J Clin Hypertens 2011; 13:332-342.
18. Assadi F. Prehypertension: A warning sign of future cardiovascular risk. Int J Prev Med 2014; 5 (Suppl 1):S4-S9.
19. Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, Batlle D. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 2002; 347:797-805.
20. ESCAPE Trial Group.Wühl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A. et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009; 361:1639-1650.
21. Ingelfinger JR. Blood-pressure control and delay in progression of kidney disease in children. N Engl J Med 2009; 361:1701-1703.
22. Flynn JT, Daniels SR, Hayman LL, Maahs DM, McCrindle BW, Mitsnefes M, et al. American Heart Association Atherosclerosis, Hypertension and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young. Update: ambulatory blood pressure monitoring in children and adolescents-A scientific statement from the American Heart Association. Hypertension 2014; 63:1116-1135.
23. Parati G, Stergiou G, O'Brien E, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 2014; 32:1359-1366.
24. Lurbe E, Torró MI, Alvarez J. Ambulatory blood pressure monitoring in children and adolescents: coming of age? Curr Hypertens Rep 2013; 15:143-149.
25. Kavey RE, Kveselis DA, Atallah N, Smith FC. White coat hypertension in childhood: evidence for end-organ effect. J Pediatr 2007; 150:491-497.
26. Matsuoka S, Awazu M. Masked hypertension in children and young adults. Pediatr Nephrol 2004; 19:651-654.
27. Stabouli S, Kotsis V, Toumanidis S, Papamichael C, Constantopoulos A, Zakopoulos N. White-coat and masked hypertension in children: association with target organ damage. Pediatr Nephrol 2005; 20:1151-1155.
28. Lurbe E, Torro I, Alvarez V, Nawrot T, Paya R, Redon J, Staessen JA. Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension 2005; 45:493-498.
29. Stergiou GS, Nasothimiou E, Giovas P, Kapoyiannis A, Vazeou A. Diagnosis of hypertension in children and adolescents based on home versus ambulatory blood pressure monitoring. J Hypertens 2008; 26:1556-1562.
30. Di Salvo G, Castaldi B, Baldini L, Gala S, del Gaizo F, D'Andrea A, et al. Masked hypertension in young patients after successful aortic coarctation repair: impact on left ventricular geometry and function. J Hum Hypertens 2011; 25:739-745.
31. Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, et al. Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol 2010; 21:137-144.
32. Lurbe E, Thijs L, Torro MI, Alvarez J, Staessen JA, Redon J. Sexual dimorphismin the transition from masked to sustained hypertension in healthy youths. Hypertension 2013; 62:410-414.
33. Salice P, Ardissino G, Barbier P, Bacà L, Li Vecchi D, Ghiglia S, et al. Differences between office and ambulatory blood pressures in children and adolescents attending a hospital hypertension clinic. J Hypertens 2013; 31:2165-2175.
34. Lurbe E. Ambulatory blood pressure in children: confidence and wisdom. J Hypertens 2013; 31:2125-2127.
35. Pini R, Cavallini MC, Palmieri V, Marchionni N, Di Bari M, Deveraux RB, et al. Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: The ICARe Dicomano Study. J Am Coll Cardiol 2008; 51:2432-2439.
36. Wang K-L, Cheng H-M, Chuang S-Y, Spurgeon HA, Ting C-T, Lakatta EG, et al. Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality? J Hypertens 2009; 27:461-467.
37. Roman MJ, Okin PM, Kizer JR, Lee ET, Howard BV, Devereux RB. Relation of central and brachial blood pressure to left ventricular hypertrophy and geometry: The Strong Heart Study. J Hypertens 2010; 28:384-388.
38. Saladini F, Santonastaso M, Mos L, Benetti E, Zanatta N, Maraglino G, Palatini P, HARVEST Study Group. Isolated systolic hypertension of young-to-middle-age individuals implies a relatively low risk of developing hypertension needing treatment when central blood pressure is low. J Hypertens 2011; 29:1311-1319.
39. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. Task Force Members.2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31:1281-1357.
40. O'Rourke MF, Vlachopoulos C, Graham RM. Spurious systolic hypertension in youth. Vasc Med 2000; 5:141-145.
41. McEniery CM, Franklin SS, Wilkinson IB, Cockcroft JR. Isolated systolic hypertension in the young: A need for clarity. J Hypertens 2013; 31:1911-1913.
42. Newman WP 3rd, Wattigney W, Berenson GS. Autopsy studies in United States children and adolescents. Relationship of risk factors to atherosclerotic lesions. Ann N Y Acad Sci 1991; 623:16-25.
43. Reusz GS, Cseprekal O, Temmar M, Kis E, Cherif AB, Thaleb A, et al. Reference values of pulse wave velocity in healthy children and teenagers. Hypertension 2010; 56:217-224.
44. Elmenhorst J, Hulpke-Wette M, Barta C, Dalla Pozza R, Springer S, Oberhoffer R. Percentiles for central blood pressure and pulse wave velocity in children and adolescents recorded with an oscillometric device. Atherosclerosis 2015; 238:9-16.
45. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, et al. Arterial stiffness and cardiovascular events: The Framingham Heart Study. Circulation 2010; 121:505-511.
46. van Sloten TT, Schram MT, van den Hurk K, Dekker JM, Nijpels G, Henry RM, Stehouwer CD. Local stiffness of the carotid and femoral artery is associated with incident cardiovascular events and all-cause mortality: The Hoorn study. J Am Coll Cardiol 2014; 63:1739-1747.
47. Mraz M, Haluzik M. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol 2014; 222:R113-R127.
48. Alvarez J, Torro MI, Aguilar F, Redon P, Lurbe E. Clustering of cardiometabolic risk factors to high blood pressure in obese youth. J Hypertens 2015; 33(Suppl 1):e23.
49. Lurbe E, Torro I, Aguilar F, Alvarez J, Alcon J, Pascual JM, Redon J. Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents. Hypertension 2008; 51:635-641.
50. Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 2009; 54:690-697.
51. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, Mietus-Snyder ML. American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Progress and challenges in metabolic syndrome in children and adolescents: A scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2009; 119:628-647.
52. Lurbe E, Garcia-Vicent C, Torro MI, Aguilar F, Redon J. Associations of birth weight and postnatal weight gain with cardiometabolic risk parameters at 5 years of age. Hypertension 2014; 63:1326-1332.
53. Brenner BM, Chertow GM. Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 1994; 23:171-175.
54. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens 1988; 1 (4 pt 1):335-347.
55. Barker DJ. The fetal origins of adult hypertension. J Hypertens Suppl 1992; 10:S39-S44.
56. Barker DJ, Martyn CN. The fetal origins of hypertension. Adv Nephrol Necker Hosp 1997; 26:65-72.
57. Hoy WE, Hughson MD, Bertram JF, Douglas-Denton R, Amann K. Nephron number, hypertension, renal disease, and renal failure. J Am Soc Nephrol 2005; 16:2557-2564.
58. Hoy WE, Ingelfinger JR, Hallan S, Hughson MD, Mott SA, Bertram JF. The early development of the kidney and implications for future health. J Develop Origins Health Dis 2010; 1:216-233.
59. Gubhaju L, Sutherland MR, Black MJ. Preterm birth and the kidney: implications for long-term renal health. Reprod Sci 2011; 18:322; DOI: 10.1177/1933719111401659.
60. Luyckx VA, Bertram JF, Brenner BM, Fall C, Hoy WE, Ozanne SE, Vikse B. Effect of fetal and child health on kidney development and longterm risk of hypertension and kidney disease. Lancet 2013; 382:273-283.
61. Abitbol CL, Bauer CR, Montane B, Chandar J, Duara S, Zilleruelo G. Long-term follow-up of extremely low birth weight infants with neonatal renal failure. Pediatr Nephrol 2003; 18:887-893.
62. Rodriguez MM, Gomez AH, Abitbol CL, Chandar JJ, Duara S, Zilleruelo GE. Histomorphometric analysis of postnatal glomerulogenesis in extremely preterm infants. Pediatr Dev Pathol 2004; 7:17-25.
63. Hodgin JB, Rasoulpour M, Markowitz GS, D'Agati VD. Very low birth weight is a risk factor for secondary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2009; 4:71-76.
64. Flynn JT, Ng DK, Chan GJ, Samuels J, Furth S, Warady B, et al. The effect of abnormal birth history on ambulatory blood pressure and disease progression in children with chronic kidney disease. J Pediatr 2014; 165:154-162e1.
65. Keijzer-Veen MG, Devos AS, Meradji M, Dekker FW, Nauta J, van der Heijden BJ. Reduced renal length and volume 20 years after very preterm birth. Pediatr Nephrol 2010; 25:499-507.
66. White SL, Perkovic V, Cass A, Chang CL, Poulter NR, Spector T, et al. Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis 2009; 54:248-261.
67. Bertram JF, Cullen-McEwen LA, Egan GF, et al. Why and how we determine nephron number. Pediatr Nephrol 2014; 29:575-580.
68. Charlton JR, Springsteen CH, Carmody JB. Nephron number and its determinants in early life: A primer. Pediatr Nephrol 2014; 29:2299-2308.
69. Nelson RG, Morgenstern H, Bennett PH. Birth weight and renal disease in Pima Indians with type 2 diabetes mellitus. Am J Epidemiol 1998; 148:650-656.
70. Abi Khalil C, Travert F, Fetita S, Rouzet F, Porcher R, Riveline JP, et al. Fetal exposure to maternal type 1 diabetes is associated with renal dysfunction at adult age. Diabetes 2010; 59:2631-2636.
71. Davis EM, Peck JD, Thompson D, Wild RA, Langlois P. Maternal diabetes and renal agenesis/dysgenesis. Birth Defects Res A Clin Mol Teratol 2010; 88:722-727.
72. Tran S, Chen Y-W, Chenier I, Chan JSD, Quaggin S, Hébert M-J, et al. Maternal diabetes induces intrarenal apoptosis and modulates renal morphogenesis in young offspring. J Am Soc Nephrol 2008; 19:943-952.
73. Geller DS. Clinical evaluation of Mendelian hypertensive and hypotensive disorders. Semin Nephrol 2010; 30:387-394.
74. Natekar A, Olds RL, Lau MW, Min K, Imoto K, Slavin TP. Elevated blood pressure: our family's fault? The genetics of essential hypertension. World J Cardiol 2014; 6:327-337.
75. Loscalzo J, Hardy DE. Epigenetic modifications: basic mechanisms and role in cardiovascular disease (2013 Grover Conference series). Pulm Circ 2014; 4:169-174.
76. Friso S, Carvajal CA, Fardella CE, Olivieri O. Epigenetics and arterial hypertension: The challenge of emerging evidence. Translat Res 2015; 165:154-165.